Cargando…

Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study

Voriconazole is a first-line antifungal agent. Therapeutic drug monitoring is a standard of care. The best way to adjust dosages to achieve desired drug exposure endpoints is unclear due to nonlinear and variable pharmacokinetics. Previously described software was used to prospectively adjust vorico...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hope, William, Johnstone, Gary, Cicconi, Silvia, Felton, Timothy, Goodwin, Joanne, Whalley, Sarah, Santoyo-Castelazo, Anahi, Ramos-Martin, Virginia, Lestner, Jodi, Credidio, Leah, Dane, Aaron, Carr, Daniel F., Pirmohamed, Munir, Salim, Rahim, Neely, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2019
Materias:	Clinical Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496160/ https://www.ncbi.nlm.nih.gov/pubmed/30670416 http://dx.doi.org/10.1128/AAC.02353-18

Ejemplares similares

Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohort
por: Turner, Richard Myles, et al.
Publicado: (2018)

Individualization of Piperacillin Dosing for Critically Ill Patients: Dosing Software To Optimize Antimicrobial Therapy
por: Felton, T. W., et al.
Publicado: (2014)

Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions
por: Osanlou, Rostam, et al.
Publicado: (2022)

Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis
por: Jiang, Zhiwen, et al.
Publicado: (2022)

Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy
por: Sime, Fekade Bruck, et al.
Publicado: (2016)

Model-Based Approach for Optimizing Ceftobiprole Dosage in Pediatric Patients
por: Rubino, Christopher M., et al.
Publicado: (2021)

β-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance
por: Jacobs, Alexandra, et al.
Publicado: (2018)

Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis
por: Lestner, Jodi, et al.
Publicado: (2017)

Effectiveness of the Med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial
por: Kiguba, Ronald, et al.
Publicado: (2022)

Voriconazole-Induced Diffuse Periostitis
por: Stefan, Simona, et al.
Publicado: (2022)

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children
por: Ramos-Martín, V., et al.
Publicado: (2017)

1566. Population Pharmacokinetics of Voriconazole: Serum Albumin Status as a Novel Marker of Clearance and Dosage Optimization
por: Chantharit, Prawat, et al.
Publicado: (2019)

Development and validation of the INappropriate solid oral dosaGE form modification aSsessmenT (INGEST) Algorithm using data of patients with medication dysphagia from a neurology ward and nursing home in Singapore
por: Tan, Poh Leng, et al.
Publicado: (2022)

Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi
por: Desai, Amit V., et al.
Publicado: (2017)

Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients
por: Felton, T W, et al.
Publicado: (2014)

Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects
por: Eckburg, Paul B., et al.
Publicado: (2019)

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model
por: Wang, Taotao, et al.
Publicado: (2018)

Response of chromoblastomycosis to voriconazole
por: de Lima, Alexandre Moretti, et al.
Publicado: (2016)

Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
por: Saini, Lalit, et al.
Publicado: (2014)

The role of tumour-derived iNOS in tumour progression and angiogenesis
por: Kostourou, V, et al.
Publicado: (2011)

Pharmacogenomics: Current State-of-the-Art
por: Carr, Daniel F., et al.
Publicado: (2014)

Statistical Primer on Biosimilar Clinical Development
por: Isakov, Leah, et al.
Publicado: (2016)

Assessing proliferation, cell-cycle arrest and apoptotic end points in human buccal punch biopsies for use as pharmacodynamic biomarkers in drug development
por: Camidge, D R, et al.
Publicado: (2005)

Therapeutic Effect of Intrastromal Voriconazole, Topical Voriconazole, and Topical Natamycin on Fusarium Keratitis in Rabbit
por: Nejabat, Mahmood, et al.
Publicado: (2016)

Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children
por: Zhao, Yi-Chang, et al.
Publicado: (2021)

Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease
por: Nixon, Gemma L., et al.
Publicado: (2018)

Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome
por: Wei, Li, et al.
Publicado: (2008)

Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease
por: Germain, Dominique P, et al.
Publicado: (2015)

Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4–dihydroxybensoic acid
por: Freyer, Christoph, et al.
Publicado: (2015)

Prescriptions and Dispensing
Publicado: (1908)

Prescriptions and Dispensing
Publicado: (1908)

Natural Mineral Waters
Publicado: (1908)

British Pharmaceutical Conference
Publicado: (1908)

The Preparation of Hot Compressed Air
Publicado: (1908)

Secret Remedies and Branded Products—VII
Publicado: (1908)

Prescriptions and Dispensing
Publicado: (1908)

Secret Remedies and Branded Products—V
Publicado: (1908)

Prescriptions and Dispensing
Publicado: (1908)

Secret Remedies and Branded Products—VI
Publicado: (1908)

Ammonia in Bismuth Subnitrate
Publicado: (1908)

Cannot write session to /tmp/vufind_sessions/sess_tgnghahae40ofj461gp8e2444r